OneSkin raises $20M to boost skin longevity science
Longevity Technology - 08-Aug-2025New funding will help expand OneSkin’s reach and target ageing at the cellular level
Join the club for FREE to access the whole archive and other member benefits.
New funding will help expand OneSkin’s reach and target ageing at the cellular level
Biotech startup’s valuation soars as it advances de novo protein generation with AI models.
With $19 million funding, the startup plans regulatory approvals and scaling
The fund bridges East-West collaboration and acts quickly using its own capital
Stentrode lets users control devices with thoughts—implanted via blood vessels, not surgery
Click on resource name for more details.
Translating Aging podcast episode- Chris and Sergey discuss how investment strategies are driving the future of longevity biotech
22-Sep-2025
Conference gathering longevity experts and investors at one place (Gstaad, Switzerland)
30-Aug-2025
Opportunity to invest in longevity with investors, longevity entrepreneurs, scientists and policy makers (Aix-en-Provence, France)
18-Jul-2025
Webinar organised by The Kitalys Institute Targeting Healthy Longevity 2025 (FREE)
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
Adrian reviews a range of finalists trying to track cancer, blood oxygenation, retinal scans, and cardiac health
Skincare product R&D budgets exceed the National Institute on Aging's budget - let's get it focussed on real anti-aging science